SCHEMBL30093073

SCHEMBL30093073

O=C(Nc1ccccc1C(=O)NCC1CCCO1)c1ccccc1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.78
HPGD P15428 3/20 0.74
ALDH1A1 P00352 5/20 0.72
NPC1 O15118 2/20 0.72
CYP1A2 P05177 1/20 0.69
CYP3A4 P08684 1/20 0.69
CYP2C9 P11712 1/20 0.69
CYP2C19 P33261 1/20 0.69
ATM Q13315 1/20 0.67
MEN1 O00255 2/20 0.64
LMNA P02545 2/20 0.62
ALOX12 P18054 2/20 0.62
GLA P06280 1/20 0.62
KDM4E B2RXH2 2/20 0.60
HSD17B10 Q99714 2/20 0.60
RCE1 Q9Y256 1/20 0.60
RAB9A P51151 2/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
ALOX15 P16050 1/20 0.58
MAPT P10636 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23412465 1.00 KMT2A (0.78) KMT2AHPGDALDH1A1NPC1CYP1A2
SCHEMBL17354444 0.91 KMT2A (0.72) KMT2AHPGDALDH1A1NPC1CYP1A2
SCHEMBL29687327 0.86 HPGD (1.00) KMT2AHPGDALDH1A1NPC1CYP1A2
SCHEMBL743611 0.86 HPGD (1.00) KMT2AHPGDALDH1A1NPC1CYP1A2
SCHEMBL30678539 0.86 HPGD (1.00) KMT2AHPGDALDH1A1NPC1CYP1A2
SCHEMBL24494843 0.85 KMT2A (0.73) KMT2AHPGDALDH1A1NPC1CYP1A2
SCHEMBL24494867 0.84 KMT2A (0.78) KMT2AHPGDALDH1A1NPC1CYP1A2
SCHEMBL18719834 0.83 KMT2A (0.74) KMT2AHPGDALDH1A1NPC1CYP1A2
SCHEMBL13162949 0.80 MAPT (0.77) KMT2AHPGDALDH1A1NPC1CYP1A2
SCHEMBL13162950 0.80 MAPT (0.77) KMT2AHPGDALDH1A1NPC1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115397806-A Aryl and heteroaryl compounds and their therapeutic use in conditions associated with altered activity of galactocerebrosidase 增益治疗股份有限公司 2022-11-25 CN disclosed